Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 13


Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective.

Silverman S, Agodoa I, Kruse M, Parthan A, Orwoll E.

J Osteoporos. 2015;2015:627631. doi: 10.1155/2015/627631. Epub 2015 Dec 9.


Changes in bone mineral density may predict the risk of fracture differently in older adults according to fall history.

Berry SD, McLean RR, Hannan MT, Cupples LA, Kiel DP.

J Am Geriatr Soc. 2014 Dec;62(12):2345-9. doi: 10.1111/jgs.13127. Epub 2014 Nov 29.


Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women.

Chao M, Hua Q, Yingfeng Z, Guang W, Shufeng S, Yuzhen D, Wei W, Haifeng T.

Pak J Med Sci. 2013 Nov;29(6):1381-4.


Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture.

Berry SD, Samelson EJ, Pencina MJ, McLean RR, Cupples LA, Broe KE, Kiel DP.

JAMA. 2013 Sep 25;310(12):1256-62. doi: 10.1001/jama.2013.277817.


Interaction between bone and muscle in older persons with mobility limitations.

Ferrucci L, Baroni M, Ranchelli A, Lauretani F, Maggio M, Mecocci P, Ruggiero C.

Curr Pharm Des. 2014;20(19):3178-97. Review.


Management of osteoporosis among the elderly with other chronic medical conditions.

Curtis JR, Safford MM.

Drugs Aging. 2012 Jul 1;29(7):549-64. doi: 10.2165/11599620-000000000-00000. Review.


Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS).

Walsh JB, Lems WF, Karras D, Langdahl BL, Ljunggren O, Fahrleitner-Pammer A, Barrett A, Rajzbaum G, Jakob F, Marin F.

Calcif Tissue Int. 2012 May;90(5):373-83. doi: 10.1007/s00223-012-9590-9. Epub 2012 Apr 1.


FRAX or fiction: determining optimal screening strategies for treatment of osteoporosis in residents in long-term care facilities.

Greenspan SL, Perera S, Nace D, Zukowski KS, Ferchak MA, Lee CJ, Nayak S, Resnick NM.

J Am Geriatr Soc. 2012 Apr;60(4):684-90. doi: 10.1111/j.1532-5415.2011.03884.x. Epub 2012 Feb 8.


Lessons learned from an osteoporosis clinical trial in frail long-term care residents.

Greenspan S, Nace D, Perera S, Ferchak M, Fiorito G, Medich D, Zukowski K, Adams D, Lee C, Saul M, Resnick N.

Clin Trials. 2012 Apr;9(2):247-56. doi: 10.1177/1740774511430516. Epub 2011 Dec 7.


Role of zoledronic acid in the prevention and treatment of osteoporosis.

Räkel A, Boucher A, Ste-Marie LG.

Clin Interv Aging. 2011;6:89-99. doi: 10.2147/CIA.S7282. Epub 2011 Mar 28. Review.


Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass.

Hamdy RC.

Drug Des Devel Ther. 2010 Nov 18;4:321-35. doi: 10.2147/DDDT.S6287. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk